C-65 , 41st Parliament, 1st session June 2, 2011, to September 13, 2013

An Act to amend the Controlled Drugs and Substances Act
Short title: Respect for Communities Act
Bill type
House Government Bill

Summary

Current status
At second reading in the House of Commons
Latest activity
Debate at second reading on June 12, 2013 (House of Commons)

Progress

End of stage activity
Introduction and first reading, June 6, 2013
Chamber sittings
Sitting date Debates (Hansard)
June 6, 2013
Chamber sittings
Sitting date Debates (Hansard)
June 12, 2013
Consideration in committee
Not reached
Report stage
Not reached
Third reading
Not reached

Senate

First reading
Not reached
Second reading
Not reached
Third reading
Not reached

Details

Recorded votes

House of Commons

There are currently no recorded votes for this bill.

Senate

To view the complete list of standing votes that have taken place in the Senate, please refer to the Votes page of the Senate of Canada website.

Speaker's rulings and statements

There are currently no Speaker's rulings and statements.

Major speeches at second reading

House of Commons

Speech date Speech Member of Parliament
June 13, 2013 Sponsor’s speech(Sitting 268) Leona Aglukkaq (Conservative)

About

Legislative summary

A legislative summary is currently being prepared for this bill by the Parliamentary Information and Research Service of the Library of Parliament. Meanwhile, the following executive summary is available.

On 6 June 2013, the Minister of Health introduced Bill C-65, An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act), in the House of Commons and it was given first reading.

Currently, under s.56 of the CDSA, the Minister has the authority to grant an exemption to undertake activities using controlled substances for a medical or scientific purpose, or in the public interest. Approximately 10,000 s.56 exemption applications are received every year, most of which are for routine activities using controlled substances from licit sources, including clinical trials, methadone treatment and university research.

Bill C-65 amends the Controlled Drugs and Substances Act to, among other things,
• create a separate exemption regime for activities involving the use of a controlled substance or precursor that is obtained in a manner not authorized under this Act;
• specify the purposes for which an exemption may be granted for those activities; and
• set out the information that must be submitted to the Minister of Health before the Minister may consider an application for an exemption in relation to a supervised consumption site.

Similar bills

No similar bills were introduced during previous sessions or Parliaments

Departmental information

Press releases

More on this bill

From the Library of Parliament

The Library of Parliament’s research publications provide non-partisan, reliable and timely information and analysis on current and emerging issues, legislation and major public policy topics.

Further reading

Export as: JSON XML

For more data options, please see Open Data

Top of page